samedan logo

 
 
spacer
home > ict > summer 2019 > the service model dichotomy
PUBLICATIONS
International Clinical Trials

The Service Model Dichotomy





In the context of progressive and steady economic growth, sponsors and CROs are continually looking for the right outsourcing models to sustain their portfolios and share complementary expertise for the long term, while ensuring flexibility in the short term. Broadly speaking, outsourcing models adhere to one of the following three approaches:

  • A full-service approach using either an exclusive or dual-vendor strategy
  • Functional approaches using different strategic vendors for different service areas
  • A more ad hoc, preferred vendor approach where competitive bidding continues

While each approach has its pros and cons, the market is quickly shifting to one of dichotomy, where either functional service provision (FSP) or full-service models are the preferred option among trial sponsors.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Daniel Chapple is a Director at Quanticate and oversees a number of functions, including commercial activities. Daniel has over 20 years of experience within the drug development field, with over 15 years spent in the CRO and business process outsourcing sector. He holds a doctorate in Biochemistry, Microbiology, and Immunology from the University of London, UK, is a Fellow of the Institute of Sales Management (FISM), and is a certified ‘green belt’ in Lean Six Sigma.


Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

Evolution Summit

4-7 May 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement